サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
市場調査レポート
商品コード
1320241

iPS細胞生産市場：タイプ別、製品別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測

Induced Pluripotent Stem Cells Production Market with COVID-19 Impact Analysis, By Type, By Product, By Application, By Country, and By Region - Industry Analysis, Market Size, Market Share & Forecast from 2023-2030
出版日: | 発行: AnalystView Market Insights | ページ情報: 英文 350 Pages | 納期: 2～3営業日

● お客様のご希望に応じて、既存データの加工や未掲載情報（例：国別セグメント）の追加などの対応が可能です。　 詳細はお問い合わせください。
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=156.58円
iPS細胞生産市場：タイプ別、製品別、用途別、国別、地域別- 産業分析、市場規模、市場シェア、2023-2030年予測
出版日: 2023年07月01日
発行: AnalystView Market Insights
ページ情報: 英文 350 Pages
納期: 2～3営業日
  • 全表示
  • 概要
  • 図表
  • 目次
概要

レポートハイライト

iPS細胞生産の市場規模は2022年に11億5,280万米ドルとなり、2023年から2030年にかけてCAGR 8.7%で拡大

iPS細胞生産市場-市場力学：

創薬・開発、細胞治療の拡大がiPS細胞生産の需要を促進すると予想される

iPS細胞は研究者に、患者固有の多能性幹細胞を作る機会を提供し、特定の疾患状態に重要なものを含む様々な細胞型に分化することができます。このことは、治療計画を立てる際に患者固有の遺伝的プロファイルや疾患プロファイルを考慮することができる個別化医療の可能性を開くものです。

iPS細胞は疾患によって影響を受ける細胞タイプに分化させることができるため、研究者は研究室内で疾患をシミュレートすることができます。その結果、薬の開発が成功する可能性が高くなり、薬のスクリーニングや試験に動物モデルを使用する頻度が減ります。傷ついたり病気になったりした組織や臓器を置き換えるために、iPS細胞は再生医療に利用される可能性があります。臓器移植の必要性をなくし、免疫学的拒絶反応の可能性を低くすることができます。

iPS細胞生産市場-主要インサイト：

  • iPS細胞生産産業は、動物の健康と栄養への関心の高まりにより、著しい速度で成長すると予測されます。
  • 製品別では、機機セグメントが2022年に最大の市場シェアを示すと予測されます。
  • 用途別では、創薬・開発セグメントが2030年までに大きな市場シェアを占めると予測されています。
  • エンドユーザー別では、バイオテクノロジー・製薬企業セグメントが2022年にリードしています。
  • 地域別では、北米が2022年の売上高をリードしています。

iPS細胞生産市場-セグメンテーション分析：

世界のiPS細胞生産市場は、タイプ、製品、用途、地域によって区分されます。

市場は製品によって2つのカテゴリーに分けられる：機器、消耗品・キット。機器セグメントが市場を独占しています。人工幹細胞の生産による需要の増加が市場成長に寄与しています。

用途別では、創薬・開発、再生医療、毒物学研究、その他の4つに分類されます。創薬・開発セグメントが市場を独占しています。幹細胞における創薬需要の増加が市場成長を後押しすると期待されています。

市場はエンドユーザー別に、研究機関、バイオテクノロジー・製薬企業、その他の3つに分類されます。バイオテクノロジー・製薬企業セグメントが市場を独占しています。幹細胞生産におけるバイオテクノロジー・製薬業界の需要の高まりが、このセグメントの成長を高めています。

iPS細胞生産市場-地理的洞察：

地理的には、この市場は北米、ラテンアメリカ、欧州、アジア太平洋、中東・アフリカの地域に広がっています。これらの地域は、ビジネスを展開する国によってさらに分けられます。

iPS細胞生産市場-競合情勢：

ヘルスケアの継続的な市場開発と医療分野からの需要の高まりが、iPS細胞生産市場に影響を与えています。企業のウェブサイトや製品を含むいくつかの流通チャネルは、企業がソリューションや製品を販売するために使用されます。製品メーカーは、製品価格、性能、製品開発、マーケティングなど様々な要因で競争しています。リーチを固め、市場シェアを拡大するために企業が用いる主な手法や戦略には、新製品の発売、研究開発費、流通網の開発、M&Aなどがあります。最近の動向の一部を以下に紹介します。

最近の動き

2021年7月、韓国に本拠を置く細胞治療会社であるSCM Lifescience Co. Ltd.は、Allele Biotechnologyという米国企業の糖尿病治療薬を紹介しました。

目次

第1章 iPS細胞生産市場概要

  • 調査範囲

第2章 エグゼクティブサマリー

  • 市場内訳
  • 競合考察

第3章 iPS細胞生産の主要な市場動向

  • iPS細胞生産市場促進要因
  • iPS細胞生産市場抑制要因
  • iPS細胞生産市場の機会
  • iPS細胞生産市場の今後の動向

第4章 iPS細胞生産産業調査

  • PEST分析
  • ポーターのファイブフォース分析
  • 成長見通しのマッピング
  • 規制枠組みの分析

第5章 iPS細胞生産市場：COVID-19の影響分析

  • COVID-19以前の影響分析
  • COVID-19以後の影響分析

第6章 iPS細胞生産市場情勢

  • iPS細胞生産市場シェア分析、2022年
  • 主要メーカー別の内訳データ
    • 確立された企業の分析
    • 新興企業の分析

第7章 iPS細胞生産市場- タイプ別

  • 概要
    • タイプ別、セグメントシェア分析
    • 機器
    • 消耗品・キット

第8章 iPS細胞生産市場-製品別

  • 概要
    • 製品別、セグメントシェア分析
    • 創薬・発見
    • 再生医療
    • 毒物学研究
    • その他

第9章 iPS細胞生産市場- 用途別

  • 概要
    • 製品別、セグメントシェア分析
    • 研究機関
    • バイオテクノロジー・製薬企業
    • その他

第10章 iPS細胞生産市場-地域別

  • イントロダクション
  • 北米
    • 概要
    • 主要メーカー
    • 米国
    • カナダ
  • 欧州
    • 概要
    • 主要メーカー
    • ドイツ
    • イタリア
    • 英国
    • フランス
    • ロシア
    • オランダ
    • スウェーデン
    • ポーランド
    • その他
  • アジア太平洋（APAC）
    • 概要
    • 主要メーカー
    • インド
    • 中国
    • 日本
    • 韓国
    • オーストラリア
    • タイ
    • インドネシア
    • フィリピン
    • その他
  • ラテンアメリカ
    • 概要
    • 主要メーカー
    • ブラジル
    • メキシコ
    • アルゼンチン
    • コロンビア
    • その他
  • 中東とアフリカ
    • 概要
    • 主要メーカー
    • サウジアラビア
    • アラブ首長国連邦
    • イスラエル
    • トルコ
    • アルジェリア
    • エジプト
    • その他

第11章 主要ベンダー分析- iPS細胞生産産業

  • 競合ダッシュボード
  • 企業プロファイル
    • Cellular Dynamics International
    • Takara Bio Inc.
    • FUJIFILM Holdings Corporation
    • Astellas Pharma Inc.
    • Thermo Fisher Scientific Inc.
    • Lonza Group AG
    • ReproCELL Inc.
    • Viacyte, Inc.
    • Fate Therapeutics Inc.
    • Cellectis
    • Century Therapeutics
    • BlueRock Therapeutics
    • Cynata Therapeutics Limited
    • Sumitomo Dainippon Pharma Co., Ltd.
    • Aastrom Biosciences, Inc.

第12章 アナリストの全方位展望

図表

List of Tables

  • TABLE List of data sources
  • TABLE Market drivers; Impact Analysis
  • TABLE Market restraints; Impact Analysis
  • TABLE Induced Pluripotent Stem Cells Production Market: Type Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Type
  • TABLE Global Induced Pluripotent Stem Cells Production Market, by Type 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cells Production Market: Product Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Product
  • TABLE Global Induced Pluripotent Stem Cells Production Market, by Product 2018-2030 (USD Million)
  • TABLE Induced Pluripotent Stem Cells Production Market: Regional snapshot (2022)
  • TABLE Induced Pluripotent Stem Cells Production Market: Application Snapshot (2022)
  • TABLE Segment Dashboard; Definition and Scope, by Application
  • TABLE Global Induced Pluripotent Stem Cells Production Market, by Application 2018-2030 (USD Million)
  • TABLE Segment Dashboard; Definition and Scope, by Region
  • TABLE Global Induced Pluripotent Stem Cells Production Market, by Region 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cells Production Market, by Country, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cells Production Market, by Type, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cells Production Market, by Product, 2018-2030 (USD Million)
  • TABLE North America Induced Pluripotent Stem Cells Production Market, by Application, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cells Production Market, by Country, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cells Production Market, by Type, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cells Production Market, by Product, 2018-2030 (USD Million)
  • TABLE Europe Induced Pluripotent Stem Cells Production Market, by Application, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cells Production Market, by Country, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cells Production Market, by Type, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cells Production Market, by Product, 2018-2030 (USD Million)
  • TABLE Asia Pacific Induced Pluripotent Stem Cells Production Market, by Application, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cells Production Market, by Country, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cells Production Market, by Type, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cells Production Market, by Product, 2018-2030 (USD Million)
  • TABLE Latin America Induced Pluripotent Stem Cells Production Market, by Application, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cells Production Market, by Country, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cells Production Market, by Type, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cells Production Market, by Product, 2018-2030 (USD Million)
  • TABLE Middle East and Africa Induced Pluripotent Stem Cells Production Market, by Application, 2018-2030 (USD Million)

List of Figures

  • FIGURE Induced Pluripotent Stem Cells Production Market Segmentation
  • FIGURE Market research methodology
  • FIGURE Value chain analysis
  • FIGURE Porter's Five Forces Analysis
  • FIGURE Market Attractiveness Analysis
  • FIGURE COVID-19 Impact Analysis
  • FIGURE Pre & Post COVID-19 Impact Comparision Study
  • FIGURE Competitive Landscape; Key company market share analysis, 2022
  • FIGURE Type segment market share analysis, 2022 & 2030
  • FIGURE Type segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Product segment market share analysis, 2022 & 2030
  • FIGURE Product segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Application segment market share analysis, 2022 & 2030
  • FIGURE Application segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Regional segment market share analysis, 2022 & 2030
  • FIGURE Regional segment market size forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE North America Induced Pluripotent Stem Cells Production Market share and leading players, 2022
  • FIGURE Europe Induced Pluripotent Stem Cells Production Market share and leading players, 2022
  • FIGURE Asia Pacific Induced Pluripotent Stem Cells Production Market share and leading players, 2022
  • FIGURE Latin America Induced Pluripotent Stem Cells Production Market share and leading players, 2022
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cells Production Market share and leading players, 2022
  • FIGURE North America market share analysis by country, 2022
  • FIGURE U.S. Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Canada Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Europe Induced Pluripotent Stem Cells Production Market share analysis by country, 2022
  • FIGURE Germany Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Spain Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Italy Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE France Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE UK Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Russia Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Netherlands Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Sweden Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Poland Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of the Europe Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Asia Pacific Induced Pluripotent Stem Cells Production Market share analysis by country, 2022
  • FIGURE India Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE China Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Japan Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE South Korea Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Australia Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Thailand Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Indonesia Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Phillipines Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of APAC Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Latin America Induced Pluripotent Stem Cells Production Market share analysis by country, 2022
  • FIGURE Brazil Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Mexico Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Argentina Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Colombia Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of LATAM Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Middle East and Africa Induced Pluripotent Stem Cells Production Market share analysis by country, 2022
  • FIGURE Saudi Arabia Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE United Arab Emirates Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Israel Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Turkey Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Algeria Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Egypt Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
  • FIGURE Rest of MEA Induced Pluripotent Stem Cells Production Market size, forecast and trend analysis, 2018 to 2030 (USD Million)
目次
Product Code: ANV1552

REPORT HIGHLIGHT

Induced Pluripotent Stem Cells Production Market size was valued at USD 1,152.8 Million in 2022, expanding at a CAGR of 8.7% from 2023 to 2030.

A type of stem cell known as induced pluripotent stem cells (iPSCs) can be produced from somatic cells like skin or blood cells through a procedure called reprogramming. iPSCs, like embryonic stem cells, have the greater capacity to develop into a variety of cell types throughout the body.

Induced Pluripotent Stem Cells Production Market- Market Dynamics:

Growing drug discovery & development, cell therapies is expected to propel the induced pluripotent stem cells production demand.

iPSCs offer researchers the opportunity to make pluripotent stem cells that are unique to a patient and can differentiate into a variety of cell types, including those important to certain disease states. This opens possibilities for personalized medicine, in which a patient's specific genetic profile and disease profile can be considered when developing a treatment plan.

iPSCs can be differentiated into cell types that are impacted by diseases, researchers can simulate diseases in a lab setting. As a result, medication development is more likely to be successful and animal models are used less frequently for drug screening and testing. To replace harmed or ill tissues and organs, iPSCs have the potential to be utilized in regenerative medicine. They can be put back into the patient after being differentiated into the desired cell type, eliminating the necessity for organ transplantation, and lowering the chance of immunological rejection.

Induced Pluripotent Stem Cells Production Market- Key Insights:

  • As per the analysis shared by our research analyst, the global Induced Pluripotent Stem Cells Production market is estimated to grow annually at a CAGR of around 8.7% over the forecast period (2023-2030)
  • The Induced Pluripotent Stem Cells Production industry is projected to grow at a significant rate due to the growing focus on animal health and nutrition.
  • Based on Product, instruments segment was predicted to show maximum market share in the year 2022.
  • Based on Application, drug development & discovery segment is expected to hold significant market share by 2030.
  • Based on End user segmentation, biotechnology & pharmaceutical companies' segment was the leading in 2022
  • On the basis of region, North America was the leading revenue generator in 2022.

Induced Pluripotent Stem Cells Production Market- Segmentation Analysis:

The Global Induced Pluripotent Stem Cells Production Market is segmented on the basis of Type, Product, Application, and Region.

The market is divided into two categories based on product: instruments, and consumables & kits. The instruments segment dominates the market. Increasing demand from induced stem cells production is contributing to market growth.

The market is divided into four categories based on Application: drug discovery & development, regenerative medicine, toxicology studies, and others. The drug discovery & development segment dominates the market. Increasing demand from drug discovery in stem cells is expected to boost the market growth.

The market is divided into three categories based on End User: research institutes, biotechnology & pharmaceutical companies, and others. The biotechnology & pharmaceutical companies segment dominates the market. The rising demand for biotech & pharmaceutical industries in stem cells production is increasing the segment growth.

Induced Pluripotent Stem Cells Production Market- Geographical Insights:

Geographically, this market is widespread into the regions of North America, Latin America, Europe, Asia Pacific, and the Middle East and Africa. These regions are further divided as per the nations bringing business.

Induced Pluripotent Stem Cells Production Market- Competitive Landscape:

Owing to the continuous development in healthcare, and rising demand from medical sector, which influence the induced pluripotent stem cells production market. Several distribution channels, including corporate websites, and products, are used by businesses to sell their solutions & products. Product manufacturers compete on various factors, such as Product pricing, performance, product creation, and marketing. reputation, and availability. Some of the primary techniques, and strategies used by corporations to consolidate their reach and expand their market share include new product launches, R&D expenditure, developing its distribution network and mergers & acquisitions. Some of the recent developments are mentioned below.

Recent Developments:

In July 2021, SCM Lifescience Co. Ltd., a South Korea based cell therapy company introduced diabetes drug from US company called Allele Biotechnology.

Key features of the study:

  • This proposed research study on Induced Pluripotent Stem Cells Production market provides market size (US$ million), compound annual growth rate (CAGR %) and forecast estimation (2023-2030), considering 2022 as the base year
  • The report provides the client the latest up-to-date and trending insights about the Induced Pluripotent Stem Cells Production market.
  • The research report elucidates potential growth opportunities across different segments/countries and explains attractive investment proposition matrix for Induced Pluripotent Stem Cells Production market
  • The overall report identifies new investment opportunities, challenges faced by established players, and growth factors to sustain in the Induced Pluripotent Stem Cells Production market
  • Impact of COVID-19 on Induced Pluripotent Stem Cells Production market size, forecast, CAGR, and market dynamics are discussed in detail under the research scope. Detailed insight on Induced Pluripotent Stem Cells Production market post-COVID will also be covered.
  • In order to give the users of this report a comprehensive view on the Induced Pluripotent Stem Cells Production market, we have also included competitive landscape and key innovator analysis for the Induced Pluripotent Stem Cells Production market.
  • The study encompasses a growth prospect mapping analysis, wherein all the industry segments are benchmarked based on their market size, growth rate and attractiveness.
  • The report offers detailed company profiling featuring major market participants which will help users to understand their financial inspection and strategic initiatives of players operating in the Induced Pluripotent Stem Cells Production market.
  • In addition, the report also unveil the important acquisitions & mergers, collaborations & joint ventures, new launch, research & development, regional expansion of major participants involved in the market on global as well as regional level.
  • The global Induced Pluripotent Stem Cells Production market report primarily caters to various stakeholders in this industry including suppliers, investors, new entrants, distributors, and financial analysts

SCOPE OF THE REPORT

The scope of this report covers the market by its major segments, which include as follows:

GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET KEY PLAYERS

  • Cellular Dynamics International
  • Takara Bio Inc.
  • FUJIFILM Holdings Corporation
  • Astellas Pharma Inc.
  • Thermo Fisher Scientific Inc.
  • Lonza Group AG
  • ReproCELL Inc.
  • Viacyte, Inc.
  • Fate Therapeutics Inc.
  • Cellectis
  • Century Therapeutics
  • BlueRock Therapeutics
  • Cynata Therapeutics Limited
  • Sumitomo Dainippon Pharma Co., Ltd.
  • Aastrom Biosciences, Inc.

GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET, BY TYPE

  • Instruments
  • Consumables & Kits

GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET, BY PRODUCT

  • Drug Development & Discovery
  • Regenerative Medicine
  • Toxicology Studies
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET, BY APPLICATION

  • Research Institutes
  • Biotechnology & Pharmaceutical Companies
  • Others

GLOBAL INDUCED PLURIPOTENT STEM CELLS PRODUCTION MARKET, BY REGION

  • North America
  • The U.S.
  • Canada
  • Europe
  • Germany
  • France
  • Italy
  • Spain
  • United Kingdom
  • Russia
  • Netherlands
  • Sweden
  • Poland
  • Rest of Europe
  • Asia Pacific
  • India
  • China
  • South Korea
  • Japan
  • Australia
  • Thailand
  • Indonesia
  • Philippines
  • Rest of APAC
  • Latin America
  • Brazil
  • Mexico
  • Argentina
  • Colombia
  • Rest of LATAM
  • The Middle East and Africa
  • Saudi Arabia
  • United Arab Emirates
  • Israel
  • Turkey
  • Algeria
  • Egypt
  • Rest of MEA

Table of Contents

1. Induced Pluripotent Stem Cells Production Market Overview

  • 1.1. Study Scope

2. Executive Summary

  • 2.1. Market Snippet
    • 2.1.1. Induced Pluripotent Stem Cells Production Market Snippet by Type
    • 2.1.2. Induced Pluripotent Stem Cells Production Market Snippet by Product
    • 2.1.3. Induced Pluripotent Stem Cells Production Market Snippet by Application
    • 2.1.4. Induced Pluripotent Stem Cells Production Market Snippet by Country
    • 2.1.5. Induced Pluripotent Stem Cells Production Market Snippet by Region
  • 2.2. Competitive Insights

3. Induced Pluripotent Stem Cells Production Key Market Trends

  • 3.1. Induced Pluripotent Stem Cells Production Market Drivers
    • 3.1.1. Impact Analysis of Market Drivers
  • 3.2. Induced Pluripotent Stem Cells Production Market Restraints
    • 3.2.1. Impact Analysis of Market Restraints
  • 3.3. Induced Pluripotent Stem Cells Production Market Opportunities
  • 3.4. Induced Pluripotent Stem Cells Production Market Future Trends

4. Induced Pluripotent Stem Cells Production Industry Study

  • 4.1. PEST Analysis
  • 4.2. Porter's Five Forces Analysis
  • 4.3. Growth Prospect Mapping
  • 4.4. Regulatory Framework Analysis

5. Induced Pluripotent Stem Cells Production Market: COVID-19 Impact Analysis

  • 5.1. Pre-COVID-19 Impact Analysis
  • 5.2. Post-COVID-19 Impact Analysis
    • 5.2.1. Top Performing Segments
    • 5.2.2. Marginal Growth Segments
    • 5.2.3. Top Looser Segments
    • 5.2.4. Marginal Loss Segments

6. Induced Pluripotent Stem Cells Production Market Landscape

  • 6.1. Induced Pluripotent Stem Cells Production Market Share Analysis, 2022
  • 6.2. Breakdown Data, by Key Manufacturer
    • 6.2.1. Established Players' Analysis
    • 6.2.2. Emerging Players' Analysis

7. Induced Pluripotent Stem Cells Production Market - By Type

  • 7.1. Overview
    • 7.1.1. Segment Share Analysis, By Type, 2022 & 2030 (%)
    • 7.1.2. Instruments
    • 7.1.3. Consumables & Kits

8. Induced Pluripotent Stem Cells Production Market - By Product

  • 8.1. Overview
    • 8.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 8.1.2. Drug Development & Discovery
    • 8.1.3. Regenerative Medicine
    • 8.1.4. Toxicology Studies
    • 8.1.5. Others

9. Induced Pluripotent Stem Cells Production Market - By Application

  • 9.1. Overview
    • 9.1.1. Segment Share Analysis, By Product, 2022 & 2030 (%)
    • 9.1.2. Research Institutes
    • 9.1.3. Biotechnology & Pharmaceutical Companies
    • 9.1.4. Others

10. Induced Pluripotent Stem Cells Production Market- By Geography

  • 10.1. Introduction
    • 10.1.1. Segment Share Analysis, By Geography, 2022 & 2030 (%)
  • 10.2. North America
    • 10.2.1. Overview
    • 10.2.2. Induced Pluripotent Stem Cells Production Key Manufacturers in North America
    • 10.2.3. North America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.2.4. North America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.2.5. North America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.2.6. North America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.7. U.S.
      • 10.2.7.1. Overview
      • 10.2.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.7.3. U.S. Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.7.4. U.S. Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.7.5. U.S. Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.2.8. Canada
      • 10.2.8.1. Overview
      • 10.2.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.2.8.3. Canada Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.2.8.4. Canada Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.2.8.5. Canada Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.3. Europe
    • 10.3.1. Overview
    • 10.3.2. Induced Pluripotent Stem Cells Production Key Manufacturers in Europe
    • 10.3.3. Europe Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.3.4. Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.3.5. Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.3.6. Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.7. Germany
      • 10.3.7.1. Overview
      • 10.3.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.7.3. Germany Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.7.4. Germany Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.7.5. Germany Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.8. Italy
      • 10.3.8.1. Overview
      • 10.3.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.8.3. Italy Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.8.4. Italy Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.8.5. Italy Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.9. United Kingdom
      • 10.3.9.1. Overview
      • 10.3.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.9.3. United Kingdom Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.9.4. United Kingdom Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.9.5. United Kingdom Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.10. France
      • 10.3.10.1. Overview
      • 10.3.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.10.3. France Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.10.4. France Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.10.5. France Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.11. Russia
      • 10.3.11.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.11.2. Russia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.11.3. Russia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.11.4. Russia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.12. Netherlands
      • 10.3.12.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.12.2. Netherlands Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.12.3. Netherlands Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.12.4. Netherlands Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.13. Sweden
      • 10.3.13.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.13.2. Sweden Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.13.3. Sweden Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.13.4. Sweden Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.14. Poland
      • 10.3.14.1. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.14.2. Poland Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.14.3. Poland Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.14.4. Poland Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.3.15. Rest of Europe
      • 10.3.15.1. Overview
      • 10.3.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.3.15.3. Rest of the Europe Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.3.15.4. Rest of the Europe Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.3.15.5. Rest of the Europe Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.4. Asia Pacific (APAC)
    • 10.4.1. Overview
    • 10.4.2. Induced Pluripotent Stem Cells Production Key Manufacturers in Asia Pacific
    • 10.4.3. Asia Pacific Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.4.4. Asia Pacific Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.4.5. Asia Pacific Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.4.6. Asia Pacific Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.7. India
      • 10.4.7.1. Overview
      • 10.4.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.7.3. India Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.7.4. India Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.7.5. India Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.8. China
      • 10.4.8.1. Overview
      • 10.4.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.8.3. China Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.8.4. China Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.8.5. China Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.9. Japan
      • 10.4.9.1. Overview
      • 10.4.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.9.3. Japan Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.9.4. Japan Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.9.5. Japan Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.10. South Korea
      • 10.4.10.1. Overview
      • 10.4.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.10.3. South Korea Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.10.4. South Korea Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.10.5. South Korea Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.11. Australia
      • 10.4.11.1. Overview
      • 10.4.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.11.3. Australia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.11.4. Australia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.11.5. Australia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.12. Thailand
      • 10.4.12.1. Overview
      • 10.4.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.12.3. Thailand Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.12.4. Thailand Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.12.5. Thailand Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.13. Indonesia
      • 10.4.13.1. Overview
      • 10.4.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.13.3. Indonesia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.13.4. Indonesia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.13.5. Indonesia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.14. Philippines
      • 10.4.14.1. Overview
      • 10.4.14.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.14.3. Philippines Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.14.4. Philippines Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.14.5. Philippines Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.4.15. Rest of APAC
      • 10.4.15.1. Overview
      • 10.4.15.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.4.15.3. Rest of APAC Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.4.15.4. Rest of APAC Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.4.15.5. Rest of APAC Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.5. Latin America
    • 10.5.1. Overview
    • 10.5.2. Induced Pluripotent Stem Cells Production Key Manufacturers in Latin America
    • 10.5.3. Latin America Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.5.4. Latin America Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.5.5. Latin America Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.5.6. Latin America Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.7. Brazil
      • 10.5.7.1. Overview
      • 10.5.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.7.3. Brazil Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.7.4. Brazil Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.7.5. Brazil Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.8. Mexico
      • 10.5.8.1. Overview
      • 10.5.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.8.3. Mexico Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.8.4. Mexico Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.8.5. Mexico Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.9. Argentina
      • 10.5.9.1. Overview
      • 10.5.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.9.3. Argentina Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.9.4. Argentina Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.9.5. Argentina Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.10. Colombia
      • 10.5.10.1. Overview
      • 10.5.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.10.3. Colombia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.10.4. Colombia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.10.5. Colombia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.5.11. Rest of LATAM
      • 10.5.11.1. Overview
      • 10.5.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.5.11.3. Rest of LATAM Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.5.11.4. Rest of LATAM Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.5.11.5. Rest of LATAM Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
  • 10.6. Middle East and Africa
    • 10.6.1. Overview
    • 10.6.2. Induced Pluripotent Stem Cells Production Key Manufacturers in Middle East and Africa
    • 10.6.3. Middle East and Africa Market Size and Forecast, By Country, 2018 - 2030 (US$ Million)
    • 10.6.4. Middle East and Africa Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
    • 10.6.5. Middle East and Africa Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
    • 10.6.6. Middle East and Africa Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.7. Saudi Arabia
      • 10.6.7.1. Overview
      • 10.6.7.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.7.3. Saudi Arabia Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.7.4. Saudi Arabia Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.7.5. Saudi Arabia Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.8. United Arab Emirates
      • 10.6.8.1. Overview
      • 10.6.8.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.8.3. United Arab Emirates Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.8.4. United Arab Emirates Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.8.5. United Arab Emirates Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.9. Israel
      • 10.6.9.1. Overview
      • 10.6.9.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.9.3. Israel Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.9.4. Israel Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.9.5. Israel Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.10. Turkey
      • 10.6.10.1. Overview
      • 10.6.10.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.10.3. Turkey Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.10.4. Turkey Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.10.5. Turkey Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.11. Algeria
      • 10.6.11.1. Overview
      • 10.6.11.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.11.3. Algeria Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.11.4. Algeria Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.11.5. Algeria Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.12. Egypt
      • 10.6.12.1. Overview
      • 10.6.12.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.12.3. Egypt Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.12.4. Egypt Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.12.5. Egypt Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)
    • 10.6.13. Rest of MEA
      • 10.6.13.1. Overview
      • 10.6.13.2. Market Analysis, Forecast, and Y-O-Y Growth Rate, 2018 - 2030, (US$ Million)
      • 10.6.13.3. Rest of MEA Market Size and Forecast, By Type, 2018 - 2030 (US$ Million)
      • 10.6.13.4. Rest of MEA Market Size and Forecast, By Product, 2018 - 2030 (US$ Million)
      • 10.6.13.5. Rest of MEA Market Size and Forecast, By Application, 2018 - 2030 (US$ Million)

11. Key Vendor Analysis- Induced Pluripotent Stem Cells Production Industry

  • 11.1. Competitive Dashboard
  • 11.2. Company Profiles
    • 11.2.1. Cellular Dynamics International
    • 11.2.2. Takara Bio Inc.
    • 11.2.3. FUJIFILM Holdings Corporation
    • 11.2.4. Astellas Pharma Inc.
    • 11.2.5. Thermo Fisher Scientific Inc.
    • 11.2.6. Lonza Group AG
    • 11.2.7. ReproCELL Inc.
    • 11.2.8. Viacyte, Inc.
    • 11.2.9. Fate Therapeutics Inc.
    • 11.2.10. Cellectis
    • 11.2.11. Century Therapeutics
    • 11.2.12. BlueRock Therapeutics
    • 11.2.13. Cynata Therapeutics Limited
    • 11.2.14. Sumitomo Dainippon Pharma Co., Ltd.
    • 11.2.15. Aastrom Biosciences, Inc.

12. 360 Degree Analyst View

13. Appendix

  • 13.1. Research Methodology
  • 13.2. References
  • 13.3. Abbreviations
  • 13.4. Disclaimer
  • 13.5. Contact Us